Clinical Trial Update: Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 trial evaluating depot naltrexone for opioid addiction; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Depot Naltrexone (naltrexone, extended-release injectable formulation (depot))

Snippet

Sponsor: University of Pennsylvania | Conditions: Opiate Addiction | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-10-23